Stacey Versavel

Stacey Versavel, PhD, serves as Senior Director of Medical Affairs at AbbVie since August 2024 and has held a similar position at Cerevel Therapeutics since February 2019, where Stacey also contributed as a Founding Colleague and Senior Director of Clinical Operations. Prior roles include Founding Colleague and Vice President of Clinical Operations at Cavion, Inc., Director of Global Program Management at Takeda, and Associate Director of Clinical Development at Biogen. At Pfizer, Stacey was an Associate Director and Senior Clinical Scientist, and began a career as a Research Scientist at Amgen. Stacey holds a MA in Molecular Biology from Brown University, a PhD in Public Health from Walden University, and a BS in Microbiology from the University of Rhode Island.